Latest Diabetes: Type II news
ADA: Insulin Efsitora Noninferior to Glargine for Reducing HbA1c in Adults With Type 2 Diabetes
posted June 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With Water
posted June 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes
posted June 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
posted June 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Related Articles
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy 
GLP-1 Receptor Agonists Linked to Lower Mortality, Amputation Rate in PAD and Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
